An open randomized clinical trial in comparing two artesunate-based combination treatments on <it>Plasmodium falciparum </it>malaria in Nigerian children: artesunate/sulphamethoxypyrazine/pyrimethamine (fixed dose over 24 hours) versus artesunate/amodiaquine (fixed dose over 48 hours)
<p>Abstract</p> <p>Background</p> <p>Several studies have demonstrated the efficacy of artemisinin-combination therapy (ACT) across malaria zones of the world. Fixed dose ACT with shorter courses and fewer tablets may be key determinants to ease of administration and co...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-12-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/9/1/378 |